Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection

medRxiv(2021)10.1101/2021.03.12.21252149Source: DataRank Database

Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (19)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Nora Pisanic ORCID,Kate Kruczynski ORCID,Tyrone Howard,Magdielis Gregory Rivera,Kristoffer Spicer

Live enrichment

PubMed:30945415 OpenAlex:https://openalex.org/W3138397042

National Institutes of Health

Grant: 5UM1AI068613-16

LC: HIV PREVENTION TRIALS NETWORK

National Institutes of Health

Grant: 2U54EB007958-11

Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases

National Institutes of Health

Grant: 5U24OD023382-07

ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)

National Institutes of Health

Grant: 2R01AI148049-21A1

Human Genetic determinants of HBV recovery

National Institutes of Health

Grant: 1U54HL143541-01

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases

National Institutes of Health

Grant: 5R01ES026973-05

Arsenic and immune response to influenza vaccination in pregnant women and newborns

National Institutes of Health

Grant: 5R01AI130066-02

Antimicrobial resistant E. coli before and after California Senate bill 27 (ARES): a natural experiment

National Institutes of Health

Grant: 1R21AI139784-01

Multiplex oral fluid antibody assay for arbovirus diagnosis, surveillance and prevention

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/03/15/2021.03.12.21252149.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.12.21252149

repositoryhttps://doi.org/10.1101/2021.03.12.21252149

Europe_PMChttps://europepmc.org/article/PPR/PPR297032

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences

Keywords

SalivaImmunologyImmune systemMedicinePopulationAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VaccinationImmunityVirologyAntigenInternal medicineDisease

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being